An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor

In an otherwise eligible patient, inadequate mobilization of PBSCs is a limiting factor to proceeding with an auto-ASCT. In such situations, plerixafor is commonly added to improve PBSC collection yields along with cytokine (G-CSF alone) or chemomobilization (chemotherapy+G-CSF). Individually, both...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Haverkos, BM, McBride, A, O’Donnell, L, Scholl, D, Whittaker, B, Vasu, S, Penza, S, Andritsos, LA, Devine, SM, Jaglowski, SM
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125480/
https://ncbi.nlm.nih.gov/pubmed/24797182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2014.90
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items